No Data
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
Zhito Hong Kong shareholder equity disclosure | October 28th
Hong Kong Shareholder Equity Disclosure | October 28th
kangji medical (09997) spent 0.5737 million Hong Kong dollars to repurchase 0.1 million shares on October 17th.
kangji medical (09997) announced that on October 17, 2024, the company invested 0.5737 million Hong Kong dollars...
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
KANGJI MEDICAL: Interim Report 2024
Behind kangji medical's (09997) six consecutive price declines triggered by a market "little episode," low-value consumables cannot support its ambition.
Even ignoring this "little episode", since the release of the 2024 interim report on August 20th, kangji medical's stock price has not shown any improvement, which is far from the nearly 15% cumulative increase in the stock price after the release of the 2023 annual report in the first half of the year. Perhaps behind this is the changing perception of investors towards the increasing national low-value consumables centralized procurement, as well as the growth curve of enterprise valuation within the industry.
Getting In Cheap On Kangji Medical Holdings Limited (HKG:9997) Is UnlikelyNo Data
No Data
